A 12-Week, Double-Blind, Randomized, Parallel Group, Placebo Controlled Study of Two Doses of VX-702 in Subjects With Moderate to Severe Rheumatoid Arthritis
A 12-Week, Double-Blind, Randomized, Parallel Group, Placebo Controlled Study of Two Doses of VX-702 in Subjects With Moderate to Severe Rheumatoid Arthritis
The purpose of this study is to assess the clinical activity and safety of two doses of VX-702 compared to placebo in subjects with moderate to severe Rheumatoid Arthritis.
Inclusion Criteria:
Exclusion Criteria:
Beograd, Serbia and Montenegro
Niska Banja, Serbia and Montenegro
Zemun, Serbia and Montenegro
Dniepropetrovsk, Ukraine
Zaporizhya, Ukraine